Member Info for EmeraldCarrots

So this is why shares generally are treading water at this level. Basically all the other countries in the World even excluding the USA will simply not allow Iran to close the straight. Expect the 30+ nation strong alliance ships to be heading to the Persion Gulf in due course................. Headed by Frances "Charles de Gaulle" nuclear powered aircraft carrier and Britains aircraft carrier Prince of Wales. Once these Countries get started Irans economy will totally ruined. Give it a week and the ships will be on their way IMHO. In 4 weeks the straight wil be opeing up IMHO.

All IMHO.

Https://oilprice.com/oil-price-charts/

in ****stan.

Out throughout the whole of the UK. One wonders if parents are warned what neonatal wards do NOT test for the possible bad reaction to antibiotics making their baby deaf !! Totally anaccepatable situation IMHO. Wes Streeting................ SORT IT OUT!

Https://www.lse.co.uk/rns/GDR/nhs-england-commercial-strategy-for-mt-rnr1-qfevlowhwjlnhra.html

Looking into what Cellbxhealth and Illumina have already found. That is the molecular examination of circulating tumour cells (CTC's) can find about TWICE as many biomarkers as analysing CtDna alone. Biomarkers can guide the best cancer treatment going forward. What more does the market want? What other companies are ABOUT to speak to Cellbxhealth to look into this also? Grail?

All IMHO.

Https://www.lse.co.uk/rns/GDR/nhs-england-commercial-strategy-for-mt-rnr1-qfevlowhwjlnhra.html

Method (does not say what is was) is uninformative. The existing study at The Royal Marsden uses GUARDIANT HEALTH. A simple search using A.I. tells us

"The Royal Marsden NHS Foundation Trust utilizes the Marsden360 liquid biopsy service, in partnership with Guardant Health, to perform molecular testing of circulating tumor DNA (ctDNA) from blood in patients with advanced (stage 3 and 4) non-small cell lung cancer (NSCLC). This service helps identify actionable mutations to guide treatment decisions.".

==============

So The Royal Marsden clearly thinks the molecular analysis of circulating tumor cells (CTC's) may provide the information that the Marsden360 liquid biopsy service, in partnership with Guardant Health is not able to (for the 10 to 15% of patients). This reminds me of the recent RNS from Grail (which sent their sp down 50% or so) which seems to suggest CtDna analysis simply cannot provide the full picture. Interesting that Myriad Genetics are already collaborating with Cellbxhealth in a similar way. Conceivably we could get a stonking RNS to say Myriad want to use our Parsortix system to catch the CTC' s for their advanced molecular analysis.

We now have both The Royal Marsden AND Myriad Cenetics looking into this. Maybe Grail have missed the boat??

All IMHO.

A.I.

"What existing Royal Marsden study involves molecular testing of ctDNA from blood in non-small cell lung cancer (NSCLC)"

============

"The Royal Marsden NHS Foundation Trust utilizes the Marsden360 liquid biopsy service, in partnership with Guardant Health, to perform molecular testing of circulating tumor DNA (ctDNA) from blood in patients with advanced (stage 3 and 4) non-small cell lung cancer (NSCLC). This service helps identify actionable mutations to guide treatment decisions.".

https://www.lse.co.uk/rns/CLBX/research-collaboration-with-the-royal-marsden-zb14dsuk4tcg0yv.html

A.I.

"What existing Royal Marsden study involves molecular testing of ctDNA from blood in non-small cell lung cancer (NSCLC)"

============

"The Royal Marsden NHS Foundation Trust utilizes the Marsden360 liquid biopsy service, in partnership with Guardant Health, to perform molecular testing of circulating tumor DNA (ctDNA) from blood in patients with advanced (stage 3 and 4) non-small cell lung cancer (NSCLC). This service helps identify actionable mutations to guide treatment decisions.".

Https://manufacturingchemist.com/cellbxhealth-royal-marsden-study-ctc-dna-lung-cancer

Research hospital are collaborating with Cellbxhealth as far as finding cancer biomarkers in blood samples goes. It seems to me that neither would be doing this unless there is useful information to be gleaned from doing so. It's pretty obvious the previous good results from Cellbxhealth / Illumina "dual analysis" (which found twice as many cancer biomarkers that CtDna analysis alone does) is finally being taken seriously. Roll on the NHS trial that was muted some time ago......... Grail could do with checking this out too, as their recent CtDna analysis of blood alone failed to reach it's goal, as we know.

All IMHO.

https://www.lse.co.uk/rns/CLBX/research-collaboration-with-the-royal-marsden-zb14dsuk4tcg0yv.html

Clinical study in 200 patients unless there is very good reason to do so. Myriad Genetics are already doing similar. CtDna analysis plus CTC analysis is already proven to find additional cancer biomarkers that can be used to guide the best treatment.

https://www.lse.co.uk/rns/CLBX/research-collaboration-with-the-royal-marsden-zb14dsuk4tcg0yv.html

All IMHO.

Https://www.find-tender.service.gov.uk/Notice/034886-2026?origin=SearchResults&p=1

So are they asking the hospitals if they want to do the 25 minute test to make sure the baby will not have a bad reaction to the antibiotic and possibly go deaf? One presumes the nurses and doctors answer would be "we would like to do the test as we do not like informing the parents that their baby has been rendered deaf by the very antibiotic we administred". LOL!

https://genedrive.com/product/mt-rnr1-id-kit/

Https://www.find-tender.service.gov.uk/Notice/034886-2026?origin=SearchResults&p=1

Preliminary market consultation. So are they asking the hospitals if they want to do the 25 minute test to make sure the baby will not have a bad reaction to the antibiotic and possibly go deaf? One presumes the nurses and doctiors answer would be "we would like to do the test as we do not like inforing the parents that their baby has been rendered deaf". LOL!

https://genedrive.com/product/mt-rnr1-id-kit/

Up 7.89%. See below.

Https://www.find-tender.service.gov.uk/Notice/034886-2026?origin=SearchResults&p=1

Https://www.find-tender.service.gov.uk/Notice/034886-2026?origin=SearchResults&p=1

Sorry. It's oil futures that are down. Current price is up.

Oil price DOWN 1.8%.

Faster than most.

... It's a HOLD imho.

..Hold.